WARRANTS TO PURCHASE COMMON STOCK (Details Narrative) |
3 Months Ended |
|---|---|
|
Mar. 31, 2025
$ / shares
shares
| |
| Class of Warrant or Right [Line Items] | |
| Number of warrants that became exercisable | shares | 10,884 |
| Number of warrants that became exercisable upon FDA acceptance of NDA filing | shares | 5,758 |
| Number of warrants expired | shares | 1 |
| Warrants One [Member] | |
| Class of Warrant or Right [Line Items] | |
| Exercise price of warrants expired (in dollars per share) | $ / shares | $ 1,056 |
| Warrants Two [Member] | |
| Class of Warrant or Right [Line Items] | |
| Exercise price of warrants expired (in dollars per share) | $ / shares | 1,776 |
| Warrants Three [Member] | |
| Class of Warrant or Right [Line Items] | |
| Exercise price of warrants expired (in dollars per share) | $ / shares | $ 364,800 |